Abstract 2 17βHSD enzymes catalyse the stereospecific oxidation/reduction at carbon 17β of androgens and 3 oestrogens, and are important players in intracrine sex hormone synthesis. The biological relevance of 4 17βHSD14, first named retSDR3, is largely unknown. We generated and validated an antibody 5 targeting the 17βHSD14 antigen and used this for immunohistochemical evaluation of expression 6 patterns in 33 healthy human tissues. Furthermore, sex steroid conversional activity in HSD17B14 7 over-expressing HEK293 and MCF10A cells was investigated by assessing interconversion products 8 of oestrone, oestradiol, androstenedione, testosterone and dehydroepiandrosterone. 9
1
Abstract 2 17βHSD enzymes catalyse the stereospecific oxidation/reduction at carbon 17β of androgens and 3 oestrogens, and are important players in intracrine sex hormone synthesis. The biological relevance of 4 17βHSD14, first named retSDR3, is largely unknown. We generated and validated an antibody 5 targeting the 17βHSD14 antigen and used this for immunohistochemical evaluation of expression 6 patterns in 33 healthy human tissues. Furthermore, sex steroid conversional activity in HSD17B14 7 over-expressing HEK293 and MCF10A cells was investigated by assessing interconversion products 8 of oestrone, oestradiol, androstenedione, testosterone and dehydroepiandrosterone. 9
Immunohistochemical staining patterns of 17βHSD14 with the enzyme being primarily expressed in 10 glandular epithelial tissue reveal an enzyme with possible implications in the secretion or conversion 11 of externally derived compounds. A role for 17βHSD14 in sex steroid metabolism is supported by the 12 finding that 17HSD14 oxidises both oestradiol and testosterone into less bioactive steroid metabolites 13 oestrone and androstenedione respectively. 14 1. INTRODUCTION 1 the 17βHSD14 antibody was performed with permission given by the Swedish animal welfare 1 authority (dnr A112-06). Peptide-neutralisation assay as well as immunoblot analysis of HSD17B14-2 transfected HEK293-and MCF10A cells confirmed antibody specificity. 3 4
Immunohistochemical evaluation of 17βHSD14 expression in various human tissues 5
Paraffin-embedded tissue micro array (TMA)-slides composed of totally 33 human tissues from 6 healthy individuals including adrenal gland (n=3), myeloid bone (n=8), breast (n=60), brain (n=14), 7 colon (n=60), eye (n=3), esophagus (n=8), heart (n=3), kidney (n=8), larynx (n=3), liver (n=8), lung 8 (n=8), lymph node (n=5), mesothelium (n=3), nerve (n=3), ovary (n=8), pancreas n= 8), parathyroid 9 gland (n=3), pituitary (n=3), prostate (n=60), rectum (n=5), salivary gland (n=3), skeletal muscle 10 (n=3), skin (n=8), duodenum (n=5), spleen (n=8), stomach (n=8), testis (n=8), thymus (n=8), thyroid 11 gland (n=3), tonsil (n=3), uterine cervix (n=8), uterus (n=3), all in 1 mm diameter cores of 5 µm 12 thickness were purchased from Tissue Array Network (Rockville, MD). TMA slides were 13 deparaffinised in xylene and then hydrated in descending concentrations of ethanol. The sections were 14 thereafter treated in a decloaking buffer (Biocare Medical, Concord, CA) in a decloaking chamber to 15 retrieve antigenicity. The temperature was allowed to reach 120°C at which the heat was turned off. 16
To reduce non-specific staining, sections were immersed in phosphate-buffered saline (PBS) 17 supplemented with 0.1 % bovine serum albumin (BSA) and then incubated with a commercial protein 18 blocking solution (Spring Bioscience, Pleasanton, CA) for 10 minutes. The tissue sections were 19 incubated with the in-house polyclonal rabbit anti-human 17βHSD14 antibody diluted to 1:1200 in 20 antibody diluent (DakoCytomation, Glostrup, Denmark) at 4°C over night. After a washing step in 21 PBS/BSA, sections were incubated with EnVision horseradish peroxidate-conjugated anti-rabbit 22 polymer (DakoCytomation) for 25 minutes. The immune reaction was visualised by incubating the 23 samples in a solution containing 3,3-diaminobenzidine chromogen supplemented with hydrogen 24 peroxide for eight minutes. Sections were briefly counterstained with hematoxylin, dehydrated in 25 ascending concentrations of ethanol and finally mounted. A test for antibody specificity was 26 performed by peptide neutralising assay. Pre-incubation of antibody and 17βHSD14-peptide was done 27 for two hours in RT with peptide (10 -6 M) and 17βHSD14 antibody (1:600) at a molar ratio of 100:1 in 1 tris-buffered saline with tween (TBST) without blocking reagent. The pre-incubation solution was 2 mixed with an equal volume of TBST supplemented with blocking solution and added to the TMA 3 tissue for overnight incubation. The TMAs were investigated microscopically using a Leica LB30T 4 microscope (Leica Microsystems, Wetzlar, Germany) by two independent investigators blinded to 5 clinical data (T.S and A.J), and the findings were confirmed by a pathologist (HO). Representative 6 slides were photographed using an Olympus SC20 digital camera (Olympus Europe GmbH, Hamburg, 7 Germany). were seeded at 16 000 cells/cm 2 in 24-well plates in 0.5 ml/well OPTIMEM phenol-red free Opti-12 MEM medium (Invitrogen, Carlsbad CA) supplemented with 4% charcoal-treated serum (CTS) 13 (Invitrogen). MCF10A cells (ATCC number CRL-10781), were seeded at at 16 000 cells/cm 2 in 24-14 well plates in 0.5 ml/well in ATCC complete growth medium supplemented with 20 ng/ml epidermal 15 growth factor, 100 ng/ml cholera toxin, 0.01 mg/ml insulin and 500 ng/ml hydrocortisone. All cells 16 were cultured at 37°C in 5% CO 2 . Twenty-four hours after seeding, the cells were transfected with a 17 Electrophoresis and western blotting was performed using the Criterion precast gel System (BioRad) . 1 The membranes with blotted proteins were blocked in TBS-tween (TBST) supplemented with 5 % 2 non-fat skimmed milk (BioRad) for 60 minutes on a shaker after which it was incubated with an in-3 house polyclonal rabbit anti-17βHSD14 antibody, diluted in blocking solution to 1:1000 at 4°C over 4 night. The membranes were then washed three times with TBST solution and incubated at ambient 5 temperature for 60 minutes with a secondary HRP-conjugated anti-rabbit IgG (DakoCytomation), 6 diluted to 1:2000 in blocking solution. The blot was washed three times in TBST and bound antibodies 7
were detected using ECL plus detection reagents (Amersham, Arlington Heights, IL). Results were 8 visualised using LAS1000 CCD-camera detection system (FujiFilm, Tokyo, Japan). A monoclonal 9
anti human β-aktin antibody (Cell Signaling, Beverly, MA) was used to control for equal loading. 10 11 2.5 Assessment of enzymatic conversion of tritiated substrates in cultured cells over-expressing 12
HSD17B14 13
Twenty four hours after transfection, cell culture media was aspired and replaced by Opti-MEM I with 14 4 % CTS supplemented with 10 nM of tritiated sex steroids; androst-4-ene-3, [1, 2, 6, 
H(N)]-, 17-15
Dione (98.1 Ci/mmol; range 70-110 Ci), oestradiol, [2, 4, 6, H(N)]-(70 Ci/mmol; range 70-115 Ci), 16 oestrone, [2,4,6,7- 3 H(N)]-(89.3 Ci/mmol; range 50-100 Ci), testosterone, [1, 2, 6, 
H(N)]-(70 17
Ci/mmol; range 70-105 Ci) and dehydroepiandrosterone, [1,2,6,7- 
Sample preparation and HPLC-analysis of steroid interconversion 24
The procedure for sample preparation, separation and detection of sex steroid interconversion product 25 has been published elsewhere [20] and was used with minor modifications. Briefly, cell culture mediasamples containing tritiated steroid interconversion products were precipitated using cold zinc 1 sulphate solution (10%) and 1 M sodium hydroxide solution. After centrifugation, supernatants were 2 transferred to injection vials for analysis. Samples were injected onto a Beckman Coulter Ultrasphere 3 ODS column, 250 x 4.6 mm, 5 µm (Bromma, Sweden), maintained at 40°C. The retention time for 4 androstenediol was experimentally determined using UV detection of unlabelled substrate. During the 5 run the autosampler was kept at 15°C. Between two and 14 minutes scintillation fluid (Ultima-Flo, 6
Perkin Elmer) was mixed with the column eluent in a 2:1 ratio enabling radiochemical detection of the 7 tritium labeled steroids. 8 9
RESULTS 10

Antibody specificity 11
Immunoblot analysis of lysates from HEK293 and MCF10A cells transiently transfected with 12 HSD17B14 revealed a single band at expected size 28 kDa. Weak or no bands were present in mock-13 transfected or non-transfected cells (Fig. 1) . When neutralized by a 17βHSD14-peptide, 14 immunopositivity in liver was not evident (Fig. 3) . 15 16
17βHSD14 distribution in human tissues 17
In order to evaluate the localisation of 17βHSD14 on a sub-tissue level we generated an antibody 18 towards the antigen and used this for immunohistochemical analysis of the protein in 33 human tissues 19 (Table 1 ). In specimens representing female reproductive organs ( Fig. 2 A-D) , uterus showed weak to 20 moderate cytoplasmic immunoreactivity in the secretory glandular epithelium of the endometrium, 21 whereas peritubular area, comprised of mainly smooth muscle, was unstained. Ovarian specimens 22
showed immunoreactivity in granulosa cells of dominant follicles as well as in atretic corpus luteum. 23
Breast specimens showed moderate to strong staining of 17βHSD14 in the cytoplasms of ductal 24 epithelial cells. Periductal stromal areas were unstained. In male reproductive organs ( Fig. 2 E and F) , 25 prostate samples showed negative to weak immunoreactivity. In testis, immunoreactivity was seen in 1 most of the seminiferous epithelium as well as in peritubular areas harbouring Leydig cells. 2 17βHSD14 was highly expressed in kidney, with samples showing strong immunoreactivity in 3 glandular cells of both proximal and distal tubules while cells of Bowman's capsule and endothelial 4 cells of glomeruli remained unstained (Fig. 3 A) . In retina, 17βHSD14 was present in cytoplasmic 5 projections of the plexiform layers whereas nuclear layers were negative, with an exception for the 6 inner nuclear layer, where staining was prominent in some nuclei (Fig. 3 B) . 17βHSD14 expression 7 was also evident in the gastrointestinal (GI) area (Fig. 3 C-F) ; in stomach samples, staining was 8 relatively strong in upper mucosal areas whereas underlying stroma was unstained. Most 17βHSD14 9 appeared to be located cytoplasmically although some nuclear staining was evident. In duodenal 10 specimens, staining was weak to moderate throughout the mucosal layer. In colon and rectal samples, 11 the presence of 17βHSD14 was especially marked at the absorptive edges of the mucosa facing the GI-12 lumen. Both enterocytes and goblet cells of the mucosal crypts stained, and although staining was 13 mostly cytoplasmic, as in the stomach, some nuclear staining was evident. In the deeper layers of the 14 mucosa, staining diminished gradually and was virtually absent below the inner muscular layer. When 15 tissues of both sexes were available, no apparent differences in staining intensities or distribution 16 patterns were seen when taking gender of tissue donor into account. 17 18
Steroid interconversion 19
In order to assess steroid conversion by 17βHSD14, HEK293 cells were transfected with an 20 expression vector containing the HSD17B14 insert. Transfected cells were thereafter exposed to 21 radiolabelled steroids, and generated tritiated products were separated by HPLC and detected by β-22 scintillation.
The rate of steroid interconversion of oestrone/oestradiol and 23 androstenedione/testosterone was obtained by integrating generated peak areas and computing ratios 24 of E1/E2 and A/T. HSD17B14 transfected cells oxidised oestradiol and testosterone to oestrone and 25 androstenedione respectively with net efficiencies of approximately 15% for the oestradiol to oestrone 26 reaction and 8% for the testosterone to androstenedione conversion compared with mock-transfectedcells. No reduction of E1, A or DHEA exceeding that of mock-transfected cells was seen for 1 HSD17B14-transfected cells (Fig. 4 A-E) . 2
DISCUSSION 3
To date, 15 isoenzymes of the 17βHSD family have been described [5, 6] . The extent to which 4 individual enzymes of this family have been studied varies. The relevance of the 17βHSD14 protein in 5 normal physiology has not been addressed, although we have previously shown tumoural expression 6 of both HSD17B14 mRNA and the 17βHSD14 protein to be of importance in breast cancer, both for Based on amino acid sequence, the enzyme was predicted to utilize NADPH as a cofactor, which 17 would render the enzyme reductive. However, using recombinant protein expressed in insect cells, the 18 authors could not detect transfer of 3 H from [ 3 H]NADPH to any of the steroid substrates tested. 19
Lukacik et al re-evaluated the same gene product in 2006 and also solved the crystal structure of 20 17βHSD14. The purified recombinant enzyme was screened against a compound library and was 21 found to convert NAD+ to NADH in the presence of oestradiol, testosterone and 5-androstenediol. 22
Oestradiol oxidation to oestrone was shown in a cell based system overexpressing HSD17B14 [2] . In 23 the current study, we utilized a similar cell based system and found significantly higher oxidation of 24 both oestradiol and testosterone into oestrone and androstenedione respectively for transient 25 HSD17B14 overexpression compared with mock-transfected cells. The relevance of 17βHSD14 as a 26 steroid-converting enzyme was strengthened by the immunohistochemical findings, which showed 27 presence of 17βHSD14 in several steroidogenic tissues including uterus, testis and breast. Among 1 female and male reproductive tissues, 17βHSD14 was most strongly expressed in uterus and testis 2 respectively, staining endometrial glands as well as male germ cells and Leydig cells, where 3 17βHSD14 may participate in the fine-tuning of the levels of bioactive sex hormones which is crucial 4 for the homeostasis in these tissues. 17βHSD14 was not expressed in prostate tissue. Among a large 5 number of normal breast samples analysed, 17βHSD14 was highly expressed in the majority. It has 6 been suggested that the predominant enzymatic direction in normal breast is oxidative, favouring E2 to 7 E1 conversion, whereas tumour progression is associated with a shift towards a reductive 8 environment, and these changes have been shown to concur with changes in local protein expression 9 of steroidogenic enzymes from a dominance of oxidative enzymes such as 17βHSD2, towards 10 increased expression of reducing enzymes, e.g. 17βHSD1 [23] [24] [25] . 11 17βHSD14 was expressed throughout the gastrointestinal tract with most prominent staining seen in 12 stomach as well as in colonic and rectal samples. In colon and rectal samples, immunoreactivity of 13 enterocytes and goblet cells of mucosal crypts was prominent in the outer absorptive border facing the 14 lumen, whereas positivity towards the deeper situated glands gradually diminished. The same pattern, 15 although not as marked, was seen in duodenal samples. Based on expression patterns in mucosal 16 layers of the colon and rectum, which resemble those published regarding other oxidizing 17βHSD 17 enzymes, e.g. type 2 and 4 in colon [26, 27] , it is suggestive that 17βHSD14 has a role in protecting 18 tissues from exposure to excess reduced steroidal agents such as ingested or bacterially derived 19 oestradiol. As proposed by English et al, the primary enzymatic activity in colonic tissue is oxidative, 20 favouring the inactivation of potent sex steroids [27] . 21
The kidney harbours several steroidogenic enzymes [28] [29] [30] . The exact significance of steroid 22 metabolism in renal cells has not been extensively studied, although observed gender differences in 23 e.g. blood pressure response to salt stimuli and the tendency to form urinary stones suggests 24 involvement of sex steroids in the regulation of tubular reabsorption [28] . In our study, 17βHSD14 25 positivity in kidney was intense and specific, present in epithelial cells of proximal and distal tubules 26 whereas renal corpuscles were negative. Specific immunopositivity for 17βHSD14 and other 17βHSD 27 enzymes such as 17βHSD5 in sites for selective ion and water transport in the kidney could possibly 1 suggest a role for 17βHSD enzymes in normal reabsorption physiology [28, 31] . 2
The HSD17B14 gene product was first cloned from a retinal cDNA-library and was also found to be 3 highly expressed therein [1] . We found 17βHSD14 immunoreactivity in cytoplasmic projections of the 4 plexiform layers of the retina, whereas nuclear layers were negative, with an exception for the inner 5 nuclear layer, where staining was prominent in specific nuclei, most likely belonging to amacrine 6 cells. Interestingly, the inner nuclear layer of the retinal epithelium has been shown to harbour the 7 highest density of steroidogenic enzymes in rat retina [32] . The presence of 17βHSD14 in retina could 8 be related to a role in steroid metabolism, but it could also be related to a possible role in retinoid 9 metabolism. 17βHSD enzymes share homology with retinol dehydrogenase enzymes, and some 10 17βHSD enzymes have been shown to metabolise retinoids [16, 33, 34] . As recently shown by Haller et 11 al. , the exchange of a single amino acid in the 17βHSD1 enzyme makes the enzyme efficiently 12 reducing all-trans-retinal to its alcohol [35] . 13
Although conversion data support a role for 17βHSD14 in sex steroid metabolism, the conversion 14 rates of these reactions are relatively low, with approximately 8-15 % of the added hydroxysteroids 15 being oxidized after 72 hours. In comparison, and as a methodological control, using the same 16 transfection system, we transiently over-expressed HSD17B2 and found 100% of added oestradiol to 17 be oxidised to oestrone within less than 24 hours. The low efficiency of 17βHSD14 in oxidising 18 hydroxysteroids could possibly suggest that the enzyme in addition operates on other, yet unknown 19 substrates. A role for 17βHSD14 in inflammatory responses is proposed by a recent interesting 20 publication by Saijo et al., in which 17βHSD14 is shown to act immunomodulatory by reducing 21 DHEA into androstenediol, which in turn is shown to be a significant inducer of anti-inflammatory 22 responses mediated by ERβ in the central nervous system [36] . When adding DHEA as a substrate to 23 transiently HSD17B14 over-expressing MCF10A cells, we detected no reduction exceeding that of 24 mock-transfected cells within 72 hours using our HPLC-based system. The reason for this apparent 25 discrepancy remains elusive, and the suggestion that 17βHSD14 would potently act as a reductive 26 enzyme as shown by Saijo et al., is intriguing as neither we, nor Lukacik et al., could detect reductive 27 activity when adding ketosteroids such as E1 or A as substrates to purified enzyme [2] or cells over-1 expressing HSD17B14. It has been shown that oxidation or reduction reactions catalysed by 17βHSD 2 enzymes are essentially reversible reactions, however, in intact cells these enzymes cause equilibrium, 3 favouring either the 17β-hydroxy conformation or the 17-keto conformation of the sex steroid, and the 4 enzymes are thus classified as either reductive or oxidative [37] . Sherbet et al., have shown that 5 whereas the E2/E1 ratio in cell culture media of cells expressing HSD17B1 could be altered by glucose 6 deprivation which causes changes in the NADPH/NADP+ ratio and thus alters the preference from E1 7 to E2 as a substrate, the preference of HSD17B2 for E2 oxidation was not affected by changes in the 8 NAD+/NADH gradient [3] . The influence on the enzymatic properties of 17βHSD14 of factors that 9 could affect cofactor availability, such as prolonged incubation times with subsequent changes in cell 10 density and pH, have not been investigated, hence there remains a possibility that differences in cell 11 culture conditions could be the cause of the dissimilar results. The discrepancy could also stem from 12 the fact that a different cell line is used or even the means of analysis used which differs between our 13 studies. Whereas Saijo et al used non-labelled steroids which after extraction from cell culture media 14 were derivatised and then separated/analysed with gas chromatography, we used radiolabelled steroids 15 which were separated via reversed phase HPLC and detected by an on-line scintillographer. Further 16 studies on the topic of 17βHSD14 substrate preference are warranted. 17
In conclusion, the 17βHSD14 enzyme is expressed in several classical steroidogenic tissues such as 18 breast, ovary and testis which supports the theory of 17βHSD14 being an actor in intracrine sex steroid 19 interconversion. This theory is further strengthened by the finding that 17βHSD14 oxidises both 20 oestradiol and testosterone in intact cells. Immunohistochemical staining patterns of 17βHSD14 with 21 the enzyme being primarily expressed in glandular epithelial cells, may implicate a role for the 22 enzyme in modulating the levels of secreted sex steroids, either endogenous or externally derived. Experiments have been performed in duplicates and repeated at least three times. 37 38 
